Fig. 7From: Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypesPexidartinib treatment does not alter T cell responses in AxD mice. Immunofluorescence for CD3 was performed and CD3+ cells quantified in the olfactory bulb glomerular layer (a) and dentate gyrus (b) per FOV. Statistical analyses: unpaired two-sided t test, n.s., non-significant (p>0.05). N = 4 per groupBack to article page